MIRAE ASSET
EMERGING BLUECHIP FUND - (MAEBF)
(Large & Mid Cap Fund - An open ended equity scheme investing in both large cap and mid cap stocks) Type of Scheme |
Large & Mid Cap Fund - An open ended equity scheme investing in both large cap and mid cap stocks |
Investment Objective |
The investment objective of the scheme is to generate income and capital appreciation from a portfolio primarily investing in Indian equities and equity related securities of large cap and mid cap companies at the time of investment. From time to time, the fund manager may also seek participation in other Indian equity and equity related securities to achieve optimal Portfolio construction. The Scheme does not guarantee or assure any returns |
Fund Managers** |
Mr. Neelesh Surana, (since inception of the fund) and Mr. Ankit Jain (since January 31, 2019) |
Allotment Date |
09th July, 2010 |
Benchmark Index |
Nifty Large Midcap 250 (TRI) |
Minimum Investment Amount |
Fresh lumpsum subscription/switch-in to all the Plans & Options of Mirae Asset Emerging Bluechip Fund through any mode including Stock Exchange platform has been temporarily suspended with effect from October 25, 2016 |
Systematic Investment Plan (SIP) (Any Date SIP is available from 1st July, 2019) |
Fresh Registration through SIP shall be allowed for a maximum of up to ₹ 2,500/-(Rupees Two Thousand Five Hundred) through Monthly mode cumulatively aggregated across all available SIP Dates of each month (at Primary holder PAN level) before the applicable cut off time on any business day For Additional Details please refer notice-cum- addendum dated November 4, 2020 |
Load Structure |
Entry load: NA Exit load: I. For investors who have opted for SWP under the plan: a) 15% of the units allotted (including Switch-in/STP - in) on or before completion of 365 days from the date of allotment of units: Nil. b) Any redemption in excess of such limits in the first 365 days from the date of allotment shall be subject to the following exit load: (Redemption of units would be done on First In First Out Basis (FIFO): •If redeemed within 1 year (365 days) from the date of allotment: 1% •If redeemed after 1 year (365 days) from the date of allotment: NIL II. Other Redemptions: For Investors who have not opted for SWP under the plan (including Switch out, STP out): •If redeemed within 1 year (365 days) from the date of allotment: 1% •If redeemed after 1 year (365 days) from the date of allotment: NIL |
Plans Available |
Regular Plan and Direct Plan |
Options Available |
Growth Option and IDCW^ Option (Payout & Re-investment) |
Monthly Average AUM (₹ Cr.) as on January 31, 2022 |
22,435.62 |
| Net AUM ( ₹ Cr.) | 22,096.58 |
Monthly Avg. Expense Ratio (Including Statutory Levies) as on January 31, 2022 |
Regular Plan: 1.69% Direct Plan: 0.70% |
| **For experience of Fund Managers Click Here | |
| ^Pursuant to Notice cum addendum dated March 27, 2021 the nomenclature of dividend option has been changed w.e.f. April 01, 2021. | |
| NAV: | Direct | Regular |
| Growth | ₹ 106.579 | ₹ 97.884 |
| IDCW | ₹ 75.712 | ₹ 45.598 |
| Volatility | 21.76% |
| Beta: | 0.92 |
| R Squared | 0.98 |
| Sharpe Ratio#: | 0.99 |
| Information Ratio | 1.33 |
| Portfolio Turnover Ratio^ | 0.68 times |
@The Volatility, Beta, R Squared, Sharpe Ratio & Information Ratio are calculated on returns from last three years Monthly data points. # Risk free rate: FBIL OVERNIGHT MIBOR as on 31st January, 2022.^Basis last rolling 12 months. |
|
| Portfolio Holdings | % Allocation | |
| Banks | ||
| ICICI Bank Ltd | 6.39% | |
| HDFC Bank Ltd | 5.22% | |
| Axis Bank Ltd | 4.70% | |
| State Bank of India | 4.00% | |
| Kotak Mahindra Bank Ltd | 0.01% | |
| Software | ||
| Infosys Ltd | 4.98% | |
| Tata Consultancy Services Ltd | 2.56% | |
| MphasiS Limited | 2.19% | |
| HCL Technologies Limited | 1.46% | |
| Pharmaceuticals | ||
| Sun Pharmaceutical Industries Ltd | 2.20% | |
| Ajanta Pharma Ltd | 1.57% | |
| IPCA Laboratories Limited | 1.38% | |
| Torrent Pharmaceuticals Ltd | 1.29% | |
| Natco Pharma Limited | 1.02% | |
| Dr. Reddy's Laboratories Ltd | 0.33% | |
| Aurobindo Pharma Ltd | 0.32% | |
| Consumer Durables | ||
| Voltas Ltd | 2.03% | |
| Bata India Limited | 1.36% | |
| Crompton Greaves Consumer Electricals Limited | 1.18% | |
| Havells India Ltd | 1.00% | |
| Titan Company Ltd | 0.11% | |
| Insurance | ||
| Max Financial Services Ltd | 2.71% | |
| HDFC Life Insurance Company Ltd | 1.21% | |
| SBI Life Insurance Company Limited | 1.12% | |
| ICICI Lombard General Insurance Company Limited | 0.41% | |
| Auto | ||
| Tata Motors Limited | 1.72% | |
| Maruti Suzuki India Ltd | 1.51% | |
| Ashok Leyland Limited | 1.41% | |
| TVS Motor Company Ltd | 0.55% | |
| Finance | ||
| Power Finance Corporation Ltd | 1.16% | |
| Shriram Transport Finance Company Limited | 1.14% | |
| Housing Development Finance Corporation Ltd | 1.12% | |
| SBI Cards and Payment Services Limited | 1.01% | |
| Cholamandalam Investment and Finance Company Limited | 0.53% | |
| Chemicals | ||
| Vinati Organics Ltd | 1.67% | |
| Atul Limited | 1.35% | |
| Chemplast Sanmar Limited | 0.96% | |
| Cement & Cement Products | ||
| JK Cement Limited | 2.55% | |
| Nuvoco Vistas Corporation Limited | 1.33% | |
| Consumer Non Durables | ||
| Emami Limited | 1.67% | |
| ITC Ltd | 1.00% | |
| Kansai Nerolac Paints Limited | 0.50% | |
| Britannia Industries Ltd | 0.43% | |
| Hindustan Unilever Ltd | 0.25% | |
| Dabur India Ltd | 0.00% | |
| Petroleum Products | ||
| Reliance Industries Ltd* | 2.88% | |
| Bharat Petroleum Corporation Limited | 0.63% | |
| Hindustan Petroleum Corporation Ltd | 0.30% | |
| Auto Ancillaries | ||
| Balkrishna Industries Ltd | 1.62% | |
| Sona BLW Precision Forgings Limited | 1.24% | |
| CEAT Limited | 0.65% | |
| Industrial Products | ||
| SKF India Limited | 2.16% | |
| Prince Pipes And Fittings Limited | 0.59% | |
| Gas | ||
| Gujarat State Petronet Limited | 2.39% | |
| Capital Markets | ||
| Indian Energy Exchange Ltd | 1.05% | |
| UTI Asset Management Company Limited | 0.88% | |
| Construction Project | ||
| Larsen & Toubro Ltd | 1.87% | |
| Ferrous Metals | ||
| Tata Steel Ltd | 1.84% | |
| Telecom - Services | ||
| Bharti Airtel Ltd | 1.79% | |
| Healthcare Services | ||
| Krishna Institute Of Medical Sciences Limited | 0.98% | |
| Fortis Healthcare Limited | 0.62% | |
| Textile Products | ||
| Page Industries Ltd | 1.39% | |
| Power | ||
| NTPC Ltd | 1.21% | |
| Transportation | ||
| Gateway Rail Freight Limited | 0.80% | |
| Aerospace & Defense | ||
| Bharat Electronics Ltd | 0.72% | |
| Pesticides | ||
| Bayer Cropscience Limited | 0.63% | |
| Financial Technology (FINTECH) | ||
| One 97 Communications Limited | 0.41% | |
| Non - Ferrous Metals | ||
| National Aluminium Company Limited | 0.12% | |
| Retailing | ||
| Zomato Limited | 0.05% | |
| Equity Holding Total | 99.42% | |
| Cash & Other Receivables | 0.58% | |
| Total | 100.00% | |
*Includes "Partly Paid Shares"
| New Position Bought |
| Stock |
| Pharmaceuticals |
| Aurobindo Pharma Limited |
| Insurance |
| ICICI Lombard General Insurance Company Limited |
| Positions Exited |
| Stock |
| Transportation |
| Gateway Distriparks Limited |
| Positions Increased |
| Stock |
| Finance |
| Cholamandalam Investment and Finance Company Limited |
| Shriram Transport Finance Company Limited |
| Housing Development Finance Corporation Limited |
| SBI Cards and Payment Services Limited |
| Non - Ferrous Metals |
| National Aluminium Company Limited |
| Industrial Products |
| Prince Pipes And Fittings Limited |
| Power |
| NTPC Limited |
| Software |
| HCL Technologies Limited |
| Infosys Limited |
| Cement & Cement Products |
| Nuvoco Vistas Corporation Limited |
| Pesticides |
| Bayer Cropscience Limited |
| Auto Ancillaries |
| Balkrishna Industries Limited |
| Consumer Non Durables |
| Emami Limited |
| Britannia Industries Limited |
| Consumer Durables |
| Havells India Limited |
| Bata India Limited |
| Banks |
| ICICI Bank Limited |
| Petroleum Products |
| Reliance Industries Limited |
| Hindustan Petroleum Corporation Limited |
| Insurance |
| HDFC Life Insurance Company Limited |
| Max Financial Services Limited |
| Pharmaceuticals |
| IPCA Laboratories Limited |
| Sun Pharmaceutical Industries Limited |
| Positions Decreased |
| Stock |
| Capital Markets |
| Indian Energy Exchange Limited |
| Aerospace & Defense |
| Bharat Electronics Limited |
| Petroleum Products |
| Bharat Petroleum Corporation Limited |
| Banks |
| Axis Bank Limited |
| HDFC Bank Limited |
| Telecom - Services |
| Bharti Airtel Limited |
| Consumer Durables |
| Voltas Limited |
| Consumer Non Durables |
| Kansai Nerolac Paints Limited |
| Healthcare Services |
| Krishna Institute Of Medical Sciences Limited |
| Auto |
| Maruti Suzuki India Limited |
| Chemicals |
| Atul Limited |
| Pharmaceuticals |
| Dr. Reddy's Laboratories Limited |
| Natco Pharma Limited |
| Industrial Products |
| SKF India Limited |
| Insurance |
| SBI Life Insurance Company Limited |
| Record Date | IDCW (₹) | Face Value (₹) | Cum Nav (₹) |
05-Jan-16 |
2.00 per Unit |
10 |
24.495 |
20-Jul-16 |
2.00 per Unit |
10 |
24.292 |
24-Jul-17 |
2.50 per Unit |
10 |
28.233 |
06-Dec-18 |
2.50 per Unit |
10 |
29.737 |
16-Jan-20 |
2.50 per Unit |
10 |
31.95 |
23-Mar-21 |
3.25 per Unit |
10 |
40.35 |
Past Performance may or may not be sustained in future. Pursuant to payment of IDCW the NAV of the IDCW option of the scheme will fall to the extent of payout and statutory levy (if any). IDCW history is for MAEBF- Regular Plan - IDCW Option
| Returns (in%) | ||||
| 1 Yr | 3 Yrs | 5 Yrs | SI | |
| MAEBF | 37.55 |
25.51 |
20.78 |
21.79 |
| Scheme Benchmark* | 37.28 |
21.48 |
17.52 |
13.71 |
| Additional Benchmark** | 26.45 |
18.26 |
17.33 |
12.22 |
| NAV as on 31st January, 2022 | 97.884 | |||
| Index Value (31st January, 2022) | Index Value of Scheme benchmark is 12,195.19 and S&P BSE Sensex (TRI) is 86,594.54 | |||
| Allotment Date | 9th July, 2010 | |||
| Scheme Benchmark | *Nifty Large Midcap 250 (TRI) | |||
| Additional Benchmark | **S&P BSE Sensex (TRI) | |||
Note:1. Different Plans under the scheme has different expense structure. The reference and details provided herein are of Regular Plan - Growth Option
2. Fund managers : Mr. Neelesh Surana managing the scheme since 9th July, 2010 & Mr. Ankit Jain since 31st ,January 2019)
| Period | Total Amount Invested | Mkt Value as on 31-January-2022 |
SIP |
1,380,000 |
5,868,013 |
10 Yrs |
1,200,000 |
4,239,517 |
7 Yrs |
840,000 |
1,800,091 |
5 Yrs |
600,000 |
1,063,156 |
3 Yrs |
360,000 |
568,000 |
1 Yr |
120,000 |
133,747 |
Returns (%) |
Period |
|||||
SI |
10yrs |
7yrs |
5yrs |
3yrs |
1yr |
|
Fund Return& (%) |
23.34 |
23.83 |
21.38 |
23.06 |
31.92 |
21.81 |
Benchmark Return& (%) |
16.68 |
17.57 |
17.78 |
20.03 |
29.65 |
21.63 |
Add. Benchmark Return& (%) |
14.36 |
15.12 |
16.28 |
18.22 |
23.21 |
16.41 |
& The SIP returns are calculated by XIRR approach assuming investment of ₹ 10,000/- on the 1st working day of every month.
This product is suitable for investors who are seeking*
• Long term capital appreciation
• Large & Midcap fund investing atleast 35% in largecap stock & atleast 35% in midcap stocks
*Investors should consult their financial advisers if they are not clear about the suitability of the product.
Past Performance may or may not be sustained in future.
Note : For computation of since inception returns (%) the allotment NAV has been taken as ₹ 10.00. The performance of other funds managed by the same fund managers are given in the respective page of the schemes 